IP Library Patent Application 10577178
Patent Application
App. No. 10/577,178

USE OF HALOARYLPYRAZOLE COMPOUNDS IN THE CONTROL OF PARASITE INFESTATION ON ANIMALS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/577,178
Abstract

The present invention relates to the use of haloarylpyrazoles as tick-repellent compositions, and to an administration regimen of specific haloarylpyrazoles for controlling ticks on animals.

Claims (75)

1 ) A method for deterring ticks from infesting an animal, wherein:

the method comprises administering a haloarylpyrazole to the animal;

the haloarylpyrazole corresponds in structure to formula (I):

Ar is 2,6-dichloro-4-trifluoromethylphenyl or 2-nitro-4-trifluoromethylphenyl;

A is S(O) m , CH═CH, O, or NH;

as to W and Z:

W is N, and Z is CR 5 ; or

W is CR 1 , and Z is N or CR 5 ;

R 1 is hydrogen, optionally substituted alkyl, halogen, or R 20 S(O) q ;

R 2 and R 3 are hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, aryl, cyano, halogen, nitro, YR 20 , S(O) 2 NR 8 R 9 , CHO, NR 8 R 9 , or CYNR 8 R 9 ;

R 4 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, acyl, or optionally substituted alkoxycarbonyl;

R 5 is hydrogen, alkyl, optionally substituted amino, or halogen;

R 8 and R 9 are independently hydrogen, optionally substituted alkyl, acyl, or aryl;

R 20 is optionally substituted alkyl;

Y is O or S;

m is zero, 1, or 2;

p is zero or 1;

n is zero, 1, or 2;

q is zero, 1, or 2;

any alkyl, alkoxy, or alkylthio comprises 1 to 4 carbon atoms;

any alkenyl or alkynyl comprises 2 to 5 carbon atoms;

any alkyl, alkoxy, alkylthio, alkenyl, or alkynyl portion of a substituted alkyl, alkoxy, alkylthio, alkenyl, or alkynyl is substituted by one or more substituents independently selected from the group consisting of halogen, YR 20 , dihalocyclopropyl, cyano, nitro, optionally substituted amino, acyloxy, and aryl;

any aryl is phenyl optionally substituted by halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, haloalkylsulphonyl, cyano, or nitro;

any acyl is alkanoyl comprising 1 to 4 carbon atoms, alkylsulphonyl, or haloalkylsulphonyl;

any optionally substituted amino is NR 8 R 9 ; and

R 4 is not alkyl when:

W is CR 1 ,

Z is CR 5 , and

n and p are both zero.

2 ) The method according to claim 1 , wherein the haloarylpyrazole is 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1-H pyrazole.

3 ) The method according to claim 1 , wherein the haloarylpyrazole is applied systemically to the animal.

4 ) The method according to claim 3 , wherein the haloarylpyrazole is applied orally to the animal.

5 ) The method according to claim 1 , wherein the haloarylpyrazole is applied as a tablet to the animal.

6 ) The method according to claim 1 , wherein the animal is a dog or cat.

7 ) The method according to claim 1 , wherein the haloarylpyrazole is applied in an initial dose of 4 mg/kg bodyweight of the animal, followed by weekly administration of doses of 2 mg/kg bodyweight of the animal.

8 ) A method for deterring ticks from infesting an animal, wherein the method comprises orally administering an initial dose of 4 mg of 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1-H pyrazole per kg bodyweight of the animal, followed by weekly oral administration of 2 mg doses of 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1H pyrazole per kg bodyweight of the animal.

9 ) The method according to claim 8 , wherein 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1-H pyrazole is administered as a tablet.

10 ) The method according to claim 8 , wherein the animal is a dog.

11 ) The method according to claim 2 , wherein the 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1-H pyrazole is applied systemically to the animal.

12 ) The method according to claim 11 , wherein the 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1-H pyrazole is applied orally to the animal.

13 ) The method according to claim 2 , wherein the animal is a dog or cat.

14 ) The method according to claim 2 , wherein the 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl-3-methyl-1-H pyrazole is applied in an initial dose of 4 mg/kg bodyweight of the animal, followed by weekly administration of doses of 2 mg/kg bodyweight of the animal.

15 ) The method according to claim 3 , wherein the animal is a dog or cat.

16 ) The method according to claim 3 , wherein the haloarylpyrazole is applied in an initial dose of 4 mg/kg bodyweight of the animal, followed by weekly administration of doses of 2 mg/kg bodyweight of the animal.

17 ) The method according to claim 4 , wherein the animal is a dog or cat.

18 ) The method according to claim 5 , wherein the animal is a dog or cat.

19 ) The method according to claim 9 , wherein the animal is a dog.

20 ) A use of a haloarylpyrazole for making a medicament to deter ticks from infesting an animal, wherein:

the haloarylpyrazole corresponds in structure to formula (I):

Ar is 2,6-dichloro-4-trifluoromethylphenyl or 2-nitro-4-trifluoromethylphenyl;

A is S(O) m , CH═CH, O, or NH;

as to W and Z:

W is N, and Z is CR 5 ; or

W is CR 1 , and Z is N or CR 5 ;

R 1 is hydrogen, optionally substituted alkyl, halogen, or R 20 S(O) q ;

R 2 and R 3 are hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, aryl, cyano, halogen, nitro, YR 20 , S(O) 2 NR 8 R 9 , CHO, NR 8 R 9 , or CYNR 8 R 9 ;

R 4 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, acyl, or optionally substituted alkoxycarbonyl;

R 5 is hydrogen, alkyl, optionally substituted amino, or halogen;

R 8 and R 9 are independently hydrogen, optionally substituted alkyl, acyl, or aryl;

R 20 is optionally substituted alkyl;

Y is O or S;

m is zero, 1, or 2;

p is zero or 1;

n is zero, 1, or 2;

q is zero, 1, or 2;

any alkyl, alkoxy, or alkylthio comprises 1 to 4 carbon atoms;

any alkenyl or alkynyl comprises 2 to 5 carbon atoms;

any alkyl, alkoxy, alkylthio, alkenyl, or alkynyl portion of a substituted alkyl, alkoxy, alkylthio, alkenyl, or alkynyl is substituted by one or more substituents independently selected from the group consisting of halogen, YR 20 , dihalocyclopropyl, cyano, nitro, optionally substituted amino, acyloxy, and aryl;

any aryl is phenyl optionally substituted by halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, haloalkylsulphonyl, cyano, or nitro;

any acyl is alkanoyl comprising 1 to 4 carbon atoms, alkylsulphonyl, or haloalkylsulphonyl;

any optionally substituted amino is NR 8 R 9 ; and

R 4 is not alkyl when:

W is CR 1 ,

Z is CR 5 , and

n and p are both zero.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2006
From: AKZO NOBEL N.V.
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 018490/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2006
From: MERTENS, CHRISTINA; DOHRMANN, HEIKE
To: AKZO NOBEL N.V.
Reel/Frame 017832/0692 →